Skip to content

Research on the Mechanisms of Ubiquitination, SUMOylation, and NEDDylation in Major Depressive Disorder

Research on the Mechanisms of Ubiquitination, SUMOylation, and NEDDylation in Major Depressive Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118657
Enrollment
Unknown
Registered
2026-02-09
Start date
2026-02-09
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Case group:None
Healthy control group:None

Sponsors

Shandong Mental Health Centre
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients in the clinical research group: 1. Age between 18 and 60 years old; 2. Signed the informed consent form; 3. Met the DSM-5 criteria for Major Depressive Disorder (MDD); 4. HAMD-17 score >= 14 points; 5. Patients who have not received treatment for the current depressive episode within the last 14 days; 6. No self-harm behavior in the past 14 days; 7. Completed primary education or above, able to understand the content of the scale; 8. Comprehended and voluntarily participated in this study, and either the individual or the legal guardian signed the informed consent form. Inclusion criteria for healthy controls in the clinical research group: 1. Age between 18 and 60 years old; 2. Signed the informed consent form; 3. In good health; 4. Completed primary education or above, able to understand the content of the scale; 5. Comprehended and voluntarily participated in this study, and either the individual or the legal guardian signed the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients in the clinical research group: 1. Currently or previously suffering from any diagnosis other than Major Depressive Disorder (MDD as per DSM-5); 2. Having severe or unstable diseases in cardiovascular, liver, kidney, endocrine and metabolic, or nervous system systems; 3. Pregnant or lactating women; 4. Those who have participated in an intervention-based clinical trial within the past 3 months; 5. Those judged by the researchers to have poor compliance or are not suitable for participation. Exclusion criteria for healthy controls in the clinical research group: 1. Currently or previously suffering from any diagnosis as per DSM-5; 2. Having severe or unstable diseases in cardiovascular, liver, kidney, endocrine and metabolic, or nervous system systems; 3. Pregnant or lactating women; 4. Those who have participated in an intervention-based clinical trial within the past 3 months; 5. Those judged by the researchers to have poor compliance or are not suitable for participation.

Design outcomes

Primary

MeasureTime frame
Differentially expressed gene;

Countries

China

Contacts

Public ContactLi Xiaojing

Shandong mental health center

lxj_2046@163.com+86 187 0531 7521

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026